Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline vs CBT for GAD after low-intensity treatment failure
NCT02347033Phase 4Terminated
- Sponsor
- University College London
- Start
- Aug 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sertraline in generalized anxiety disorder (GAD) (2 arms), sponsored by University College London. Primary endpoint: Generalized Anxiety Disorder-7 at 12 months. Started Aug 2014; status: terminated.
02
Drugs
sertraline
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT02347033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02347033.